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Abstract
Background: Decoding of the liver proteome is subject of intense research, but hampered by
methodological constraints. We recently developed an improved protocol for studying rat liver
proteins based on 2-DE-MALDI-TOF-MS peptide mass finger printing.
This methodology was now applied to develop a mouse liver protein database.
Results: Liver proteins were extracted by two different lysis buffers in sequence followed by a
liquid-phase IEF pre-fractionation and separation of proteins by 2 DE at two different pH ranges,
notably 5-8 and 7-10. Based on 9600 in gel digests a total of 643 mouse liver proteins with high
sequence coverage (> 20 peptides per protein) could be identified by MALDI-TOF-MS peptide
mass finger printing. Notably, 255 proteins are novel and have not been reported so far by
conventional two-dimensional electrophoresis proteome mapping. Additionally, the results of the
present findings for mouse liver were compared to published data of the rat proteome to compile
as many proteins as possible in a rodent liver database.
Conclusion: Based on 2-DE MALDI-TOF-MS a significantly improved proteome map of mouse
liver was obtained. We discuss some prominent members of newly identified proteins for a better
understanding of liver biology.
Background
Life is incompatible without the liver as this organ per-
forms essential metabolic functions. Estimates suggest an
excess of > 10,000 biochemical reactions at any given time
point, and this includes basic carbohydrate, fat and pro-
tein metabolism; storage of vitamins and minerals; many
regulatory functions that control blood sugar and hor-
mone levels. Indeed, the liver is the primary organ for the
synthesis of many different proteins, such as plasma albu-
min, fibrinogen and most globulins, as well as lipids and
lipoproteins (phospholipids, cholesterol) and is responsi-
ble for bile acid production and excretion. Being exposed
to a wide range of xenobiotics and toxins the liver has the
remarkable capacity for regenerative growth. In fact, up to
75% of the liver can be surgically removed, before it ceases
to function [1], but will return to its original size through
regenerative growth within a few weeks.
It is of considerable importance that the human and
mouse genome display > 99% DNA sequence similarity.
Consequently, this laboratory animal is widely used in
biomedical research, for instance, in the evaluation of
novel experimental therapeutics. Despite the genetic sim-
ilarity, their proteomes differ considerably. Therefore,
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translating findings from mice to humans requires an
understanding of the differences in regard to physiology,
pathology and response to toxicants [2]. In the past, sev-
eral investigators attempted to identify mouse [3-5] and
rat [6-8] liver proteins by use of the 2-D PAGE technique,
aiming to build up databases of rodent proteomes [9]. As
early as 1981, Klose and Feller investigated the mouse
liver proteome by 2-DE PAGE [3]. At present, several data-
bases of mouse liver [10-13] and of subcellular fractions
such as mitochondria [14], microsomes [15], peroxi-
somes [16] and nuclear proteome [17] are available. For
instance, Fountoulakis et al. [11] reported a total of 256
unique mouse liver proteins in their efforts to identify
proteins regulated by the analgesic drug acetaminophen
and to explore possible mechanisms of hepatotoxicity.
Furthermore, 328 unique proteins (cytosolic and mito-
chondrial/microsomal proteins) were reported in a subse-
quent publication to increase knowledge on the mouse
liver proteome [12]. In this regard, 107 mouse liver pro-
teins were identified by Sanchez et al. [13] by 2-DE PAGE
followed by in gel tryptic digest and mass spectrometry.
Finally, a total of 182 unique proteins were reported by
Da Cruz et al. [14] and traced back to the mouse liver
mitochondrial inner membrane.
Here, we report our efforts to map the proteome of mouse
liver. In total, we identified 643 proteins and some iso-
forms. Indeed, 255 proteins identified by us have not
been reported so far by two-dimensional electrophoresis
proteome mapping and when compared with published
databases such as the one published by Fountoulakis et al.
[11,12] (see also http://expasy.org/world-2dpage). Specif-
ically, we applied our recently published protocol to map
liver proteins by use of a combination of different frac-
tionation methods (a liquid-phase IEF pre-fractionation,
the use of two different pH ranges, 5-8 and 7-10 and two
different lysis buffers in sequence) in order to reduce the
complexity of the protein extract and to increase the prob-
ability of detecting low-abundance proteins.
Overall, we aimed at developing a proteome map and to
make this database publicly available to assist researchers
in their studies on liver biology.
Materials and methods
Materials
A UP 200S Sonicator (Dr. Hielscher GmbH, Stuttgart, Ger-
many) was used to homogenate the samples. For the first
dimension, immobilized pH gradient (IPG) strips (17 cm,
pH 5-8 and 7-10) were purchased from Bio-Rad (Her-
cules, CA, USA). The pre-fractionation was carried out
with a Rotofor Cell (Bio-Rad). The focusing chamber was
a Protean Isoelectric Focusing (IEF) Cell (Bio-Rad). For
the second dimension a Protean plus Dodeca Cell (Bio-
Rad) was used.
Reagents (tris, urea, thiourea, CHAPS, dithiothreitol,
bromophenol blue, glycerin, sodium dodecyl sulfate, gly-
cin, temed, ammonium peroxodisulfate, ammonium sul-
fate, ammonium bicarbonate, colloidal coomassie blue
and acrylamide) were purchased from Roth (Karlsruhe,
Germany). Iodacetamide was from SERVA (Heidelberg,
Germany). Benzonase was purchased from Novagen
(Darmstadt, Germany). Ampholytes (biolyte 3-10) were
purchased from Bio-Rad. DeStreak was purchased from
Amersham Bioscience (Freiburg, Germany).
Animal care
A total of n = 6 C57/Bl6 male mice (aged 6-8 months)
weighing 25-33 g were housed in Makrolon® Type III
cages. Drinking water and food (V1124-000, SSNIFF, The
Netherlands) were given ad libitum. The temperature and
relative humidity were 22 ± 2°C and 40-70%, respec-
tively. Furthermore, a 12-h day and night cycle was used.
For liver explantation, mice were anesthetized with Keta-
min 10% 100 μL/100 g and Xylazin 2% 50 μL/100 g, and
after surgical removal the liver was washed until free of
blood.
Mouse liver sample preparation
Approximately 0.1 g of the liver sample was ground in a
mortar under liquid nitrogen flow. Then, the samples
were processed with 0.5 mL of a buffer containing 40 mM
tris base, 7 M urea, 4% CHAPS, 100 mM DTT and 0.5%
(v/v) biolyte 3-10 first (LB2). The suspensions were
homogenized by sonication (3 × 20 s) and after addition
of 3 μL of benzonase (endonuclease that degrades DNA
and RNA) were incubated at room temperature for 20
min. The samples were then centrifuged at 12,000 g for 20
min. The pellets were washed and sonicated for 5 min
with a further 0.5 mL of LB2 and centrifuged at 12,000 g
for another 20 min, and the resulting two fractions of
supernatant were collected (extract A) (Figure 1). Finally,
the pellets were dissolved with 0.5 mL of buffer contain-
ing 40 mM tris base, 5 M urea, 2 M thiourea, 4% CHAPS,
100 mM DTT, 0.5% (v/v) biolyte 3-10 (LB3), sonicated
and centrifuged at 12,000 g for 20 min. The pellet was col-
lected, and the supernatant was marked as extract B (Fig-
ure 1).
From the same animals, a further 0.1-g portion was
ground in a mortar, but treated this time with 0.5 mL of
LB3. The suspensions were sonicated, incubated with ben-
zonase and centrifuged. The pellets were then washed
with another 0.5 mL of LB3, sonicated and centrifuged,
and the supernatants were collected (extract C) (Figure 1).
Proteome mapping was done under a variety of condi-
tions, e.g. extraction with lysis buffers 2 and 3. In addi-
tion, proteins were separated at two different pH ranges
(5-8 and 7-10). A total of 4 experiments were carried out,Proteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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and duplicate measurements were run for each experi-
ment (Figure 2). Overall approximately 9600 spots, cut
from 24 gels, could thus be investigated. The protein con-
centration of all extracts was determined using the Brad-
ford assay.
Liquid-phase IEF pre-fractionation
The liquid-phase IEF pre-fractionation was performed in
the Rotofor Cell system (Bio-Rad) following the instruc-
tions of the supplier. Ion exchange membranes were
equilibrated overnight in the appropriate electrolyte
(anion exchange membranes in NaOH 0.1 M and cation
exchange membranes in H3PO4 0.1 M). After four runs,
ion exchange membranes were always discarded and
replaced by new membranes for the other samples. For
each run, the electrode chambers were filled with fresh
appropriate electrolytes (30 mL). Initially, the cell was
filled with pure water and run for 5 min at 5 W constant
power to remove residual ionic contaminants from the
membrane core and ion exchange membranes. Approxi-
mately 32 mL of LB2 were used to fill the cell. A total of
60 mg of total proteins in approximately 2 mL of LB2 were
added to the cell to reach the maximum loadable volume
(40 mL). Focusing started at 12 W constant power. After
approximately 4 h, the voltage increased to 3000 V and
the wattage decreased to 3 W. The focused proteins were
harvested in 20 ~ 1.5 mL fractions, and pH values were
checked. Fractions having pH values between 3 and 7.0
were collected and denoted as "A-a" (acid) (Figure 2).
Fractions having pH values > 7.0 were collected and
denoted as "A-b" (basic) (Figure 2). Again the protein
concentration was determined for both fractions (A-a and
A-b) by the Bradford method. Approximately 30 mg of
protein were recovered at the end of the liquid-phase IEF
pre-fractionation from an initial 60 mg load. The losses
are accounted for by the multi-step pre-fractionation pro-
cedure, but are not the result of a precipitate that could
not be dissolved in our lysis buffer. Other investigations
have reported similar losses during pre-fractionation; for
instance, see Fountoulakis et al. [18], or P.G. Righetti et al.
Outline of protein extraction procedures Figure 1
Outline of protein extraction procedures. A) sequential extraction with LB2 (7 M urea) and LB3 (5 M urea, 2 M thiou-
rea). B) direct extraction with LB3 (5 M urea, 2 M thiourea).Proteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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[19]. After each run, the membrane core was cleaned with
NaOH 0.1 M overnight and sonicated for 5 min in water
before the new focusing.
Two-dimensional gel electrophoresis
Isoelectric focusing (IEF) - first dimension
IEF was performed using precast linear IPG strips. The 17-
cm IPG strips 7-10 and 5-8 were loaded with 1.5 mg of
proteins by active rehydration (12 h, 50 V). Samples des-
tined to be separated by IPG strips 7-10 received an excess
of hydroxyethyl disulfide (HED) (DeStreak™) prior to the
focusing run. Focusing began at 250 V for 20 min in rapid
mode, increasing to 10,000 V for 5 h in linear mode and
10,000 V for 50,000 Vh in rapid mode (for the IPG strips
5-8). IEF for the strips 7-10 was carried out at 250 V for 60
min in rapid mode, then at 10,000 V for 3 h in linear
mode and at 10,000 V for 50,000 Vh in rapid mode. Each
sample was analyzed in duplicate (Figure 2).
2-DE - second dimension
After IEF, the IPG strips were either stored at -80°C or
transferred to 10 mL of equilibration buffer (6 M urea,
30% w/v glycerin, 2% w/v SDS, 50 mM Tris-HCl pH 8.8)
with 2% w/v DTT and 0.5% v/v bromophenol blue solu-
tion (0.25% w/v bromophenol blue, 1.5 M Tris-HCl pH
8.8, 0.4% w/v SDS) and incubated for 20 min at room
temperature. Strips were removed and incubated in equi-
libration buffer with 4% w/v iodoacetamide and 0.5% v/
v bromophenol blue solution for further 20 min at room
temperature. Finally, the strips and 10 μL SDS-PAGE
molecular weight standard on filter paper were placed on
top of the 20 cm × 20.5 cm 12% second-dimension gel
Proteome mapping of mouse liver Figure 2
Proteome mapping of mouse liver. A pre-fractionation step prior to the IEF was carried out for the samples 1A-6A to 
separate proteins in two fractions: acid proteins with pH values < 7 (1A-a; 6A-a) and basic proteins having pH values > 7 (1A-
b; 6A-b). All fractions were run in duplicate modus for the first and second dimensions. In summary, three experiments (E = 1, 
E = 3, E = 4) were repeated for the samples in the pH range 5-8. One experiment (E = 2) was carried out using the pH range 
7-10. A total of 24 gels (grey small boxes) were used for cutting, digestion and MS identification of the spots/proteins. (N° = 
number; E = experiment; A-a = extract in LB2, acidic fraction; A-b = extract in LB3, basic fraction).Proteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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(12% v/v acrylamide/bis solution, 375 mM Tris, pH 8.8,
0.1% v/v SDS, 1/2000 TEMED, 0.05% v/v APS). Both were
fixed in place with a 0.5% w/v agarose overlay. Gels were
run in PROTEAN Plus Dodeca cell from Bio-Rad at 70 V
for approximately 14 h, followed by 200 V until the
bromophenol blue dye reached the bottom of the gel. The
running buffer (25 mM Tris, 0.2 M glycin, 0.1% SDS) was
cooled externally to 16°C.
Gels/proteins were fixed overnight in 30% ethanol and
2% phosphoric acid and washed 3 × 20 min with 2%
phosphoric acid. The gels were equilibrated with 15%
ammonium sulfate, 18% ethanol and 2% phosphoric
acid for 15 min and finally stained with colloidal coomas-
sie blue for 48 h.
Gel scanning and image analysis
After staining, gels were washed 10 min with pure water
and scanned on a Molecular FX Scanner Bio-Rad at 100
μm resolution. Protein spots were imaged first automati-
cally and then manually and analyzed using the
PDQuest™ software Bio-Rad. The normalization was car-
ried out in total density in gel mode according to the man-
ufacturer's recommendation.
Matrix-assisted laser desorption ionization mass 
spectrometry (MALDI-MS)
A total of 9600 spots derived from 24 gels were excised
using the spot cutter of Bio-Rad and placed into 96-well
microtiter plates. Excised gel spots were washed manually
with 20 μL of water for 10 min and destained twice, first
with 15 μL ammonium bicarbonate 50 mM for 5 min and
then with 15 μL 50% ammonium bicarbonate 50 mM -
50% acetonitrile for 5 min. Finally, the gel particles were
covered by acetonitrile until gel pieces shrunk and left to
dry for 10 min. All gels/proteins were digested manually
in situ with 4 μL of ammonium bicarbonate 50 mM con-
taining 20 ng trypsin (Sequencing Grade Modified
Trypsin Promega). After 15 min, each gel piece was re-
swelled with 10 μL of ammonium bicarbonate 50 mM
and incubated for 4 h at 37°C. After 4 h, the reaction was
stopped by adding 10 μL of trifluoroacetic acid 1% con-
taining 1.5% (w/v) n-octyl-β-D-glucopyranoside (OGP)
(AppliChem). For the application of the samples, 4 μL of
peptide solution were loaded on an MTP Anchor Chip
Target 600/384 (Bruker Daltonics) previously prepared
with a saturated solution of matrix, α-cyano-4-hydroxy-
cinnamic acid (α-HCCA) (Bruker Daltonics). An external
calibration was performed by spotting on the 96 calibra-
tion positions of the Anchor Chip Target 1 μL of the pep-
tide calibration standards (Bruker Daltonics) containing
the following peptides: angiotensin II (1046.5420 Da),
angiotensin I (1296.6853 Da), substance P (1347.7361
Da), bombesin (1619.8230 Da), ACTH clip 1-17
(2093.0868 Da), ACTH clip 18-39 (2465.1990 Da),
somatostatin 28 (3147.4714 Da) and OGP 1.5% (w/v).
Samples were analyzed in a MALDI-TOF-TOF spectrome-
ter (Ultraflex, Bruker Daltonics) using an accelerating
voltage of 25 kV for the Peptide Mass Fingerprint (PMF)
mode. When necessary, MALDI-Post Source Decay (PSD)
analysis was carried out using the LIFT special technique
delivered by Bruker (the basic idea of LIFT is to lift the
potential to fragment the selected peptides of interest).
Peptide matching and protein searches were performed
automatically with the MASCOT software. For the PMF
search the parameters were the following: C-carbaimid-
omethyl (fixed modification), M-oxidation (variable
modification), monoisotopic (mass value), 100 ppm
(peptide mass tolerance), 1 (max missed cleavage), mam-
malia (taxonomy). Five matching peptides and at least
10% peptide coverage of the theoretical sequences was the
minimal requirement for an identity assignment. For the
MS/MS search (PSD) the parameters were the same except
the peptide mass tolerance, which was 200 ppm. The
identified proteins were organized with the ProteinScape™
database (Bruker Daltonics) and checked individually and
only mouse proteins or highly homologous sequences
from other mammalian species, like Homo sapiens or Rat-
tus Norvegicus, having pI and Mw values close to the theo-
retical, were considered (a total of n = 39 proteins).
Optimization of the IEF for proteins in the basic pH range
Isoelectric focusing of proteins in the acidic and basic pH
ranges is often associated with streaking, due to disappear-
ance of the reducing agent, normally DTT, from the basic
part of the IPG strip, followed by oxidation of the protein
thiol groups, resulting in a heterogeneous mixture of inter
and intra chain -S-S- bonds and causing a train of extra
artifactual spots.
To decrease the streaking of basic proteins we tested: a)
different IEF programs, b) the use of an electrode paper
pad at the cathode as a source of DTT during focusing and
c) the use of hydroxyethyl disulfide (DeStreak™).
Results
Protein extraction and separation
We employed two strategies to extract mouse liver pro-
teins: a) sequential extraction with lysis buffers LB2 and
LB3; b) extraction with LB3 only (Figure 1). For some pro-
teins the use of two lysis buffers in sequence improved
considerably the number of detectable and identifiable
spots as reported herein.
We optimized the separation of proteins in the basic pH
range during the IEF [8]. We analyzed mouse liver protein
extracts on two narrow pH range IPG strips (pH 5-8 and
pH 7-10) (Figure 2) and processed 24 2-DE gels to yield
approximately 9600 gel digests. Of the approximately
9600 spots studied many were redundant proteins. TakenProteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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collectively, a total of 643 unique proteins were identified,
including several isoforms. To the best of our knowledge,
255 proteins have not been reported so far in previous 2-
DE liver proteome maps (Figure 3, Additional File 1).
We also investigated the sensitivity, linear range and com-
patibility of stain for identification by mass spectrometry
[8] and used a liquid-phase IEF pre-fractionation in order
to reduce the complexity of the samples and to enrich for
low-abundance proteins [8]. The additional files 2 and 3
depict two gels each for the pH ranges 5-8 and 7-10.
Peptide mass fingerprinting
After in gel tryptic digest the proteins were analyzed by
MALDI-TOF/TOF (Ultraflex, Bruker Daltonic). Identifica-
tion of proteins was carried out by database searches with
MASCOT. A total of 643 coomassie-stained proteins were
identified and could be traced back to 390 different gene
products. Not all isoforms could be identified, because in
some cases the identified peptides were identical in
sequence (see Additional file 4 where sequences of all
peptide mass fingerprints are given). Additional file 5
gives additional information, e.g. the names of the identi-
fied proteins, accession numbers in SwissProt, gene
names, functions and biological processes. Furthermore,
we provide information on the lysis buffer used, how fre-
quently the protein was identified, how many spots for
each protein were observed, the subcellular location and
which of the proteins are in common between mouse and
rat liver. In Additional file 4 we report: the molecular
weight, theoretical pI, MASCOT score, together with
sequence coverage (%), the number of identified peptides
and the sequence of peptides. Notably, on average 20 pep-
tides per protein could be identified giving rise to a high
sequence coverage.
Subcellular location
The identified proteins were assigned to various subcellu-
lar compartments of the cell, e.g. the cytoplasm, mito-
chondria, endoplasmic reticulum (ER) and the nucleus.
For about 83% of the proteins in the Additional file 5,
entries in the Swiss-Prot or Gene Ontology (GO) data-
bases were found. The distribution of the identified pro-
teins according to cell compartments is depicted in Figure
4A. Notably, most of the proteins are cytosolic or mito-
chondrial (118 and 39, respectively). For a total of 67
(17%) proteins no subcellular locations are known. It is of
considerable importance that after extraction with LB2 78
proteins could be identified and were of cytosolic, mito-
chondrial, or mitochondrial matrix origin (see Additional
file 5 column "lysis buffer"). These proteins were neither
found in extract B nor C.
Biological function
The identified proteins were categorized according to their
biological function (Figure 4B). For approximately 90%
of the proteins at least one annotation term within the
Gene Ontology (GO) was found. About 214 proteins
(54%) are involved in metabolism and code, for example,
for oxidoreductase, transferases, hydrolases, lyase and
ligases. A total of 16 proteins were identified with inferred
functions in apoptosis. Among them was the 78 kDa glu-
cose-regulated protein, which plays a role in facilitating
the assembly of multimeric protein complexes inside the
ER (Swiss-Prot: P07823). A total of 24 chaperone pro-
teins, involved in protein folding, were identified, includ-
ing a 170 kDa glucose-regulated protein which delivers
copper to zinc superoxide dismutase.
Further proteins with different biological functions were
identified, including structural proteins (5%), transport
proteins (7%), nucleic acid enzymes (3%) and proteins
(4%) involved in catabolic processes, like the proteasome
machinery. We also identified 14 proteins (4%) involved
in transcription, such as the similar to transcriptional acti-
vator protein pur-alpha (purine-rich single-stranded
DNA-binding protein alpha) and 9 (2%) xenobiotic/
detoxification proteins (Figure 4B). Finally, 40 (10%) pro-
teins had no entries in GO concerning their biological
function.
Discussion
Because of the liver's tremendous importance in basic
metabolism and its frequent injury by drugs and chemi-
cals, research on the liver proteome has received much
Comparison of three mouse liver proteomes Figure 3
Comparison of three mouse liver proteomes. Our 
map of the mouse liver proteome comprises 390 proteins 
(643 including the isoforms), 255 of which were not previ-
ously identified by others. * The number ofproteins was 
obtained by adding the data of two articles [11,12]. ** The 
proteins are freely available at http:/expasy.org/world-
2dpage.Proteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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attention. As of today, several reports on mouse liver pro-
teomes are available, but differ with regard to number and
abundance of reported proteins [2-17]. Here, we com-
pared our mouse liver proteome map with those reported
by others, thereby evidencing which proteins are novel. To
the best of our knowledge, a total of 368 proteins have so
far been reported for mouse liver based on 2-DE/MS
[11,12]. We report further insight into the mouse liver
proteome by employing a combination of different lysis
buffers, a pre-fractionation method of proteins prior to
the first dimension and the use of two different pH gradi-
ents to map as many proteins as possible from mouse liver
extracts. As described in our previous work, the use of
thiourea in addition to urea improved solubility, espe-
cially of membrane proteins.
To separate complex protein mixtures, additional dissolv-
ing power is needed. The use of narrow-range IPGs (e.g.
pH 5-8 and 7-10) allowed us to further reduce the com-
plexity of the protein extract and enabled visualization of
a greater number of protein spots. The pH range 3-10 was
not used in this study, because we already demonstrated
its limited advantage in our previous work [8]. Most of the
proteins have a pI in the pH range of 5-8. Here, we report
643 proteins, 255 of which have not been reported so far
by two-dimensional electrophoresis proteome mapping,
when compared with published findings. These proteins
are listed in Additional file 1 and are grouped according to
their biological processes. Some interesting examples are
discussed below.
We identified proteins involved in programmed cell death
[20,21]. This process is tightly controlled and involves the
coding of death factors and death receptors. Apoptosis is
frequently disabled in tumour growth to foster cell prolif-
eration. Specifically, we identified the eukaryotic initia-
tion factor 5A (Swiss-Prot: P63242). This
nucleocytoplasmic shuttle protein is involved in cell pro-
liferation and apoptosis [22]. Overexpression of eIF5A, a
protein known to undergo posttranslational modification
by deoxyhypusine synthase, induced apoptosis in colon
carcinoma cells and was shown to be required for expres-
sion of p53 following an induction of apoptosis upon
treatment of the cells with actinomycin D. Unhypusinated
eIF5A may have pro-apoptotic functions and is rapidly
translocated to the nucleus following the induction of
apoptotic cell death [22].
A further example of the newly identified mouse liver pro-
tein is the hepatoma-derived growth factor (Swiss-Prot:
P51859), e.g. a heparin-binding protein with mitogenic
activity in fibroblasts. This protein plays an important role
in liver development and regeneration as well as hepato-
carcinogenesis [23].
Among the transcription factor proteins identified, we
report the similar to transcriptional activator protein pur-
alpha (Swiss-Prot: P42669) as an example. Probably, this
transcription activator binds the purine-rich single strand
of the PUR element located upstream of the c-Myc gene. It
may play a role in the initiation of DNA replication, in
recombination and may even be involved in apoptosis,
cell differentiation, cell proliferation, negative regulation
of transcription, positive regulation of cell proliferation
and regulation of transcription [24].
Furthermore, we identified several xenobiotic  defense
proteins, examples of which are aldehyde dehydrogenase
A: Subcellular location of identified mouse liver proteins Figure 4
A: Subcellular location of identified mouse liver pro-
teins. The Swiss-Prot and Gene Ontology databases were 
used for the protein annotation. B: Biological function of 
identified mouse liver proteins. The proteins were classified 
into 19 functional groups. The metabolism group was subdi-
vided into 8 subgroups, such as oxidoreductase, transferase 
etc. The Swiss-Prot and Gene Ontology databases were used 
for the protein annotation.Proteome Science 2009, 7:35 http://www.proteomesci.com/content/7/1/35
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1 family, member B1(Q9CZS1), biphenyl hydrolase-like
(Q8R164), esterase D/formylglutathione hydrolase
(Q9R0P3) and aldo-keto reductase family 1, members
C12 and C13 (Q91X42, Q8VC28). All of these proteins
play a role in detoxification of alcohol-derived acetalde-
hyde, corticosteroids, biogenic amines, neurotransmitters
and lipid peroxidation products [25-28].
Moreover, we identified more than 10 proteins involved
in protein folding. Examples are heat shock protein gp96
(Q29092), trap1 protein (Q922Z3) and the 170 kDa glu-
cose-regulated protein (Q60432).
Notably, in a most recent study of Lai et al. [29], a com-
prehensive and quantitative proteome map of the mouse
liver and plasma was reported [29]. The authors compiled
7099 proteins based on an identification of two peptides
per protein. This extraordinary high number of proteins
was, however, reduced to 2857, when 4 peptides were
determined for their identification. In our efforts we
obtained on average a sequence coverage of 20 peptides or
more to yield 643 unique proteins including some iso-
forms. Based on our experimental strategy > 50 novel pro-
teins could be identified that were not reported by Lai et
al. (Figure 5) [Additional file 6]. This was surprising as
many are of high abundance. Importantly, these proteins
are of great importance in liver biology and regulation of
some of these proteins in disease is well documented. For
instance, we uniquely identified heat shock protein 90
(Hsp90) that has become a target for therapy in diverse
human malignancies [30]. Another protein identified by
us is cofilin-1 that was found to be down-regulated in liver
cancer [31]. This protein controls reversibly actin polym-
erization and depolymerization in a pH-sensitive manner
and it is the major component of intranuclear and cyto-
plasmic actin rods. In an attempt to identify biomarkers
that could distinguish cancerous and non malignant liver
tissues, Lee and co-workers developed a classifier model
based on the expression of six biomarkers that included
cathepsin B and cytochrome b5. Once again these pro-
teins were not reported in the study of Lai et al but were
clearly identified in our approach. Notably, these biomar-
kers were significantly associated with serum AFP levels in
clinical cases of HCC [32]. Others not reported by Lai et al
but identified in the present study are catalase, glutath-
ione synthetase, ferritin light chain, peroxiredoxin-1,
major urinary protein 1, all of which are abundant pro-
teins. Presumably, the sample work flow in the study of
Lai et al and probably low efficiencies in the ionisation of
these proteins may hamper their identification. Overall,
our study highlights the need to confirm independently
the growing database for liver proteins. Apart from the
uniquely identified proteins there was good agreement
between the data reported by Lai et al [29] and the one
reported herein.
Conclusion
In conclusion, we aimed at an identification of as many
proteins as possible to further map the mouse liver pro-
teome by using two different lysis buffers, a pre-fractiona-
tion method prior to the IEF and the application of two
different IPG strips. The proteins were identified by
MALDI-TOF/TOF mass spectrometry after in gel digests of
approximately 9600 spots, derived from 24 gels. The pro-
tocol described herein is not limited to the mouse liver
and may well be applied to other tissues. Our efforts to
decode the mouse liver proteome resulted in an identifi-
cation of 643 proteins, and they contribute to an
improved understanding of liver biology.
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